Continuous glucose monitor for older adults with type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older.
- You have type 2 diabetes.
- You take at least two different oral diabetes medications and have been on the same types for the past 3 months.
- Your most recent A1c level was between 7.5% and 10%.
- You own a smartphone that works with a continuous glucose monitor.
- You have not used insulin or a GLP-1 agonist in the past 3 months.
- You have not used any continuous glucose monitor in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This trial tests whether using a continuous glucose monitor (CGM) when you leave the hospital helps control blood sugar better. If you have type 2 diabetes and use insulin, you may be able to join.
This study tests a new way to diagnose diabetes in older adults by using a continuous glucose monitor (CGM) — a small sensor worn on the arm — to get a more accurate picture of blood sugar than the standard A1c test alone. If you qualify, you'll wear the sensor for about 48 days, and the results may help your doctor know whether you truly have diabetes.
This trial tests if using a continuous glucose monitor (a small sensor that checks your sugar levels without fingersticks) helps young adults manage type 2 diabetes better. You will wear the sensor and use a phone app to track your glucose.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This study tests two continuous glucose monitors (CGMs) worn on the arm to see how accurate and safe they are. A CGM is a small device that checks your blood sugar levels without finger pricks. The trial lasts about 17 days and involves wearing two sensors at the same time.
Hear when a new Diabetes Mellitus Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.